Related Experiment Video
Updated: Aug 3, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Elderly patients at risk for coronary heart disease or stroke: selecting an ideal product for lipid lowering
1Lipid Disorders Clinic, Georgetown University Medical Center, 3800 Reservoir Road, NW, Washington, DC 20007, USA.
Insights
Statins effectively lower cholesterol and lipids in older adults, potentially preventing heart disease and stroke. These drugs may improve blood vessel function and normalize clotting, crucial for cardiovascular health in the elderly.
Area of Science:
- Cardiovascular Medicine
- Geriatrics
- Pharmacology
Background:
- Coronary heart disease (CHD) disproportionately affects individuals over 65, accounting for 84% of deaths.
- Stroke incidence significantly increases with age, doubling each decade after 55.
- Elevated cholesterol and lipid levels are key risk factors for cardiovascular events.
Purpose of the Study:
- To review the role of statins in managing cardiovascular risk factors in the elderly.
- To explore the mechanisms by which statins may prevent coronary events and stroke.
Main Methods:
- Review of large clinical trials on statin efficacy.
- Analysis of studies investigating statin effects on endothelial function and coagulation.
Main Results:
- Statins demonstrate efficacy in lowering cholesterol and lipids in middle-aged and elderly populations.
- Evidence suggests statins can improve endothelial function and vasodilation.
- Statins may normalize thrombin formation, impacting clot regulation.
Conclusions:
- Statins are a vital therapeutic option for reducing cardiovascular risk in older adults.
- Improved endothelial function and normalized coagulation are potential mechanisms for statin-mediated event prevention.
- Further research into statin's pleiotropic effects may enhance cardiovascular protection strategies.
Abstract:
Coronary heart disease is an affliction of the elderly: 84% of those who die from the disease are over 65 years of age. In patients over 55 years, the incidence of stroke more than doubles with each decade of life. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, or statins, have been shown to lower cholesterol and lipids in both middle-aged and elderly patients in large clinical trials. Some statins have been shown to improve endothelial function and vasodilation and to normalize thrombin formation, which may be among the mechanisms involved in both coronary event and stroke prevention.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Coronary Artery Disease IV: Preventive Measures
Angina IV: Management
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management

